Key Points

  • TERT rare variants are present in 2.7% of MDS patients and associated with increased nonrelapse mortality after stem cell transplant.

  • As a group, TERT rare variants have impaired telomere elongation capacity in cells and likely disrupt domain-specific functions.

Abstract

Germline pathogenic TERT variants are associated with short telomeres and an increased risk of developing myelodysplastic syndrome (MDS) among patients with a telomere biology disorder. We identified TERT rare variants in 41 of 1514 MDS patients (2.7%) without a clinical diagnosis of a telomere biology disorder who underwent allogeneic transplantation. Patients with a TERT rare variant had shorter telomere length (P < .001) and younger age at MDS diagnosis (52 vs 59 years, P = .03) than patients without a TERT rare variant. In multivariable models, TERT rare variants were associated with inferior overall survival (P = .034) driven by an increased incidence of nonrelapse mortality (NRM; P = .015). Death from a noninfectious pulmonary cause was more frequent among patients with a TERT rare variant. Most variants were missense substitutions and classified as variants of unknown significance. Therefore, we cloned all rare missense variants and quantified their impact on telomere elongation in a cell-based assay. We found that 90% of TERT rare variants had severe or intermediate impairment in their capacity to elongate telomeres. Using a homology model of human TERT bound to the shelterin protein TPP1, we inferred that TERT rare variants disrupt domain-specific functions, including catalysis, protein–RNA interactions, and recruitment to telomeres. Our results indicate that the contribution of TERT rare variants to MDS pathogenesis and NRM risk is underrecognized. Routine screening for TERT rare variants in MDS patients regardless of age or clinical suspicion may identify clinically inapparent telomere biology disorders and improve transplant outcomes through risk-adapted approaches.

REFERENCES

1.
Savage
SA
,
Bertuch
AA.
The genetics and clinical manifestations of telomere biology disorders
.
Genet Med
.
2010
;
12
(
12
):
753
-
764
.
10.1097/GIM.0b013e3181f415b5
2.
Agarwal
S.
Evaluation and management of hematopoietic failure in dyskeratosis congenita
.
Hematol Oncol Clin North Am
.
2018
;
32
(
4
):
669
-
685
.
10.1016/j.hoc.2018.04.003
3.
Schratz
KE
,
DeZern
AE.
Genetic predisposition to myelodysplastic syndrome in clinical practice
.
Hematol Oncol Clin North Am
.
2020
;
34
(
2
):
333
-
356
.
10.1016/j.hoc.2019.10.002
4.
Schratz
KE
,
Haley
L
,
Danoff
SK
, et al
.
Cancer spectrum and outcomes in the Mendelian short telomere syndromes
.
Blood
.
2020
;
135
(
22
):
1946
-
1956
.
10.1182/blood.2019003264
5.
Kirwan
M
,
Vulliamy
T
,
Marrone
A
, et al
.
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia
.
Hum Mutat
.
2009
;
30
(
11
):
1567
-
1573
.
10.1002/humu.21115
6.
de Witte
T
,
Bowen
D
,
Robin
M
, et al
.
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
.
Blood
.
2017
;
129
(
13
):
1753
-
1762
.
10.1182/blood-2016-06-724500
7.
Bartenstein
M
,
Deeg
HJ.
Hematopoietic stem cell transplantation for MDS
.
Hematol Oncol Clin North Am
.
2010
;
24
(
2
):
407
-
422
.
10.1016/j.hoc.2010.02.003
8.
Myllymäki
M
,
Redd
R
,
Reilly
CR
, et al
.
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome
.
Blood
.
2020
;
136
(
26
):
3070
-
3081
.
10.1182/blood.2020005397
9.
Blackburn
EH
,
Epel
ES
,
Lin
J.
Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection
.
Science
.
2015
;
350
(
6265
):
1193
-
1198
.
10.1126/science.aab3389
10.
Demanelis
K
,
Jasmine
F
,
Chen
LS
, et al;
GTEx Consortium
.
Determinants of telomere length across human tissues
.
Science
.
2020
;
369
(
6509
):
eaaz6876
.
10.1126/science.aaz6876
11.
Grill
S
,
Nandakumar
J.
Molecular mechanisms of telomere biology disorders
.
J Biol Chem
.
2020
;
296
:
100064
.
10.1074/jbc.REV120.014017
12.
Alter
BP
,
Giri
N
,
Savage
SA
,
Rosenberg
PS.
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up
.
Haematologica
.
2018
;
103
(
1
):
30
-
39
.
10.3324/haematol.2017.178111
13.
Marsh
JCW
,
Gutierrez-Rodrigues
F
,
Cooper
J
, et al
.
Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms
.
Blood Adv
.
2018
;
2
(
1
):
36
-
48
.
10.1182/bloodadvances.2017008110
14.
Yamaguchi
H
,
Calado
RT
,
Ly
H
, et al
.
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia
.
N Engl J Med
.
2005
;
352
(
14
):
1413
-
1424
.
10.1056/NEJMoa042980
15.
Calado
RT
,
Regal
JA
,
Kajigaya
S
,
Young
NS.
Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations
.
Eur J Clin Invest
.
2009
;
39
(
11
):
1025
-
1032
.
10.1111/j.1365-2362.2009.02209.x
16.
Collopy
LC
,
Walne
AJ
,
Vulliamy
TJ
,
Dokal
IS.
Targeted resequencing of 52 bone marrow failure genes in patients with aplastic anemia reveals an increased frequency of novel variants of unknown significance only in SLX4
.
Haematologica
.
2014
;
99
(
7
):
e109
-
e111
.
10.3324/haematol.2014.105320
17.
Tsakiri
KD
,
Cronkhite
JT
,
Kuan
PJ
, et al
.
Adult-onset pulmonary fibrosis caused by mutations in telomerase
.
Proc Natl Acad Sci USA
.
2007
;
104
(
18
):
7552
-
7557
.
10.1073/pnas.0701009104
18.
Armanios
MY
,
Chen
JJ-L
,
Cogan
JD
, et al
.
Telomerase mutations in families with idiopathic pulmonary fibrosis
.
N Engl J Med
.
2007
;
356
(
13
):
1317
-
1326
.
10.1056/NEJMoa066157
19.
Newton
CA
,
Batra
K
,
Torrealba
J
, et al
.
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive
.
Eur Respir J
.
2016
;
48
(
6
):
1710
-
1720
.
10.1183/13993003.00308-2016
20.
Alder
JK
,
Hanumanthu
VS
,
Strong
MA
, et al
.
Diagnostic utility of telomere length testing in a hospital-based setting [correction published in Proc Natl Acad Sci USA. 2018;115(18):34312]
.
Proc Natl Acad Sci USA
.
2018
;
115
(
10
):
E2358
-
E2365
.
10.1073/pnas.1720427115
21.
Diaz de Leon
A
,
Cronkhite
JT
,
Katzenstein
A-LA
, et al
.
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations
.
PLoS One
.
2010
;
5
(
5
):
e10680
.
10.1371/journal.pone.0010680
22.
Petrovski
S
,
Todd
JL
,
Durheim
MT
, et al
.
An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis
.
Am J Respir Crit Care Med
.
2017
;
196
(
1
):
82
-
93
.
10.1164/rccm.201610-2088OC
23.
Gorgy
AI
,
Jonassaint
NL
,
Stanley
SE
, et al
.
Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders
.
Chest
.
2015
;
148
(
4
):
1019
-
1026
.
10.1378/chest.15-0825
24.
Donaires
FS
,
Scatena
NF
,
Alves-Paiva
RM
, et al
.
Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma
.
PLoS One
.
2017
;
12
(
8
):
e0183287
.
10.1371/journal.pone.0183287
25.
Parry
EM
,
Alder
JK
,
Qi
X
,
Chen
JJ
,
Armanios
M.
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase [correction published in Blood. 2016;127(14):1837]
.
Blood
.
2011
;
117
(
21
):
5607
-
5611
.
10.1182/blood-2010-11-322149
26.
Armanios
M
,
Chen
J-L
,
Chang
Y-PC
, et al
.
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita
.
Proc Natl Acad Sci USA
.
2005
;
102
(
44
):
15960
-
15964
.
10.1073/pnas.0508124102
27.
Vulliamy
T
,
Marrone
A
,
Szydlo
R
,
Walne
A
,
Mason
PJ
,
Dokal
I.
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
.
Nat Genet
.
2004
;
36
(
5
):
447
-
449
.
10.1038/ng1346
28.
Greider
CW
,
Blackburn
EH.
Telomeres, telomerase and cancer
.
Sci Am
.
1996
;
274
(
2
):
92
-
97
.
10.1038/scientificamerican0296-92
29.
Nguyen
THD
,
Tam
J
,
Wu
RA
, et al
.
Cryo-EM structure of substrate-bound human telomerase holoenzyme
.
Nature
.
2018
;
557
(
7704
):
190
-
195
.
10.1038/s41586-018-0062-x
30.
Smith
EM
,
Pendlebury
DF
,
Nandakumar
J.
Structural biology of telomeres and telomerase
.
Cell Mol Life Sci
.
2020
;
77
(
1
):
61
-
79
.
10.1007/s00018-019-03369-x
31.
Podlevsky
JD
,
Bley
CJ
,
Omana
RV
,
Qi
X
,
Chen
JJ-L.
The telomerase database
.
Nucleic Acids Res
.
2008
;
36
(
Database issue
):
D339
-
D343
.
32.
Richards
S
,
Aziz
N
,
Bale
S
, et al;
ACMG Laboratory Quality Assurance Committee
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
.
Genet Med
.
2015
;
17
(
5
):
405
-
424
.
10.1038/gim.2015.30
33.
Nykamp
K
,
Anderson
M
,
Powers
M
, et al;
Invitae Clinical Genomics Group
.
Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria [correction published in Genet Med. 2020;22:240]
.
Genet Med
.
2017
;
19
(
10
):
1105
-
1117
.
10.1038/gim.2017.37
34.
Miosge
LA
,
Field
MA
,
Sontani
Y
, et al
.
Comparison of predicted and actual consequences of missense mutations
.
Proc Natl Acad Sci USA
.
2015
;
112
(
37
):
E5189
-
E5198
.
10.1073/pnas.1511585112
35.
Ernst
C
,
Hahnen
E
,
Engel
C
, et al
.
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics
.
BMC Med Genomics
.
2018
;
11
(
1
):
35
.
10.1186/s12920-018-0353-y
36.
Ghosh
R
,
Oak
N
,
Plon
SE.
Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
.
Genome Biol
.
2017
;
18
(
1
):
225
.
10.1186/s13059-017-1353-5
37.
Armbruster
BN
,
Banik
SS
,
Guo
C
,
Smith
AC
,
Counter
CM.
N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo
.
Mol Cell Biol
.
2001
;
21
(
22
):
7775
-
7786
.
10.1128/MCB.21.22.7775-7786.2001
38.
Counter
CM
,
Hahn
WC
,
Wei
W
, et al
.
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
.
Proc Natl Acad Sci USA
.
1998
;
95
(
25
):
14723
-
14728
.
10.1073/pnas.95.25.14723
39.
Zaug
AJ
,
Crary
SM
,
Jesse Fioravanti
M
,
Campbell
K
,
Cech
TR.
Many disease-associated variants of hTERT retain high telomerase enzymatic activity
.
Nucleic Acids Res
.
2013
;
41
(
19
):
8969
-
8978
.
10.1093/nar/gkt653
40.
Lindsley
RC
,
Saber
W
,
Mar
BG
, et al
.
Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation
.
N Engl J Med
.
2017
;
376
(
6
):
536
-
547
.
10.1056/NEJMoa1611604
41.
Gibson
CJ
,
Lindsley
RC
,
Tchekmedyian
V
, et al
.
Clonal hematopoiesis associated with adverse outcomes after autologous stem0cell transplantation for lymphoma
.
J Clin Oncol
.
2017
;
35
(
14
):
1598
-
1605
.
10.1200/JCO.2016.71.6712
42.
Boettcher
S
,
Miller
PG
,
Sharma
R
, et al
.
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
.
Science
.
2019
;
365
(
6453
):
599
-
604
.
10.1126/science.aax3649
43.
Jiang
J
,
Wang
Y
,
Sušac
L
, et al
.
Structure of telomerase with telomeric DNA
.
Cell
.
2018
;
173
(
5
):
1179
-
1190.e13
.
10.1016/j.cell.2018.04.038
44.
Jiang
J
,
Chan
H
,
Cash
DD
, et al
.
Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions
.
Science
.
2015
;
350
(
6260
):
aab4070
.
10.1126/science.aab4070
45.
Wang
F
,
Podell
ER
,
Zaug
AJ
, et al
.
The POT1-TPP1 telomere complex is a telomerase processivity factor
.
Nature
.
2007
;
445
(
7127
):
506
-
510
.
10.1038/nature05454
46.
Huang
J
,
Brown
AF
,
Wu
J
, et al
.
Structural basis for protein-RNA recognition in telomerase
.
Nat Struct Mol Biol
.
2014
;
21
(
6
):
507
-
512
.
10.1038/nsmb.2819
47.
Hoffman
H
,
Rice
C
,
Skordalakes
E.
Structural analysis reveals the deleterious effects of telomerase mutations in bone marrow failure syndromes
.
J Biol Chem
.
2017
;
292
(
11
):
4593
-
4601
.
10.1074/jbc.M116.771204
48.
Kelley
LA
,
Mezulis
S
,
Yates
CM
,
Wass
MN
,
Sternberg
MJE.
The Phyre2 web portal for protein modeling, prediction and analysis
.
Nat Protoc
.
2015
;
10
(
6
):
845
-
858
.
10.1038/nprot.2015.053
49.
Kircher
M
,
Witten
DM
,
Jain
P
,
O’Roak
BJ
,
Cooper
GM
,
Shendure
J.
A general framework for estimating the relative pathogenicity of human genetic variants
.
Nat Genet
.
2014
;
46
(
3
):
310
-
315
.
10.1038/ng.2892
50.
Karczewski
KJ
,
Francioli
LC
,
Tiao
G
, et al;
Genome Aggregation Database Consortium
.
The mutational constraint spectrum quantified from variation in 141,456 humans [correction published in Nature. 2021;590:E53]
.
Nature
.
2020
;
581
(
7809
):
434
-
443
.
10.1038/s41586-020-2308-7
51.
Alirezaie
N
,
Kernohan
KD
,
Hartley
T
,
Majewski
J
,
Hocking
TD.
ClinPred: prediction tool to identify disease-relevant nonsynonymous single-nucleotide variants
.
Am J Hum Genet
.
2018
;
103
(
4
):
474
-
483
.
10.1016/j.ajhg.2018.08.005
52.
Calado
RT
,
Regal
JA
,
Hills
M
, et al
.
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
.
Proc Natl Acad Sci USA
.
2009
;
106
(
4
):
1187
-
1192
.
10.1073/pnas.0807057106
53.
Tesmer
VM
,
Smith
EM
,
Danciu
O
,
Padmanaban
S
,
Nandakumar
J.
Combining conservation and species-specific differences to determine how human telomerase binds telomeres
.
Proc Natl Acad Sci USA
.
2019
;
116
(
52
):
26505
-
26515
.
10.1073/pnas.1911912116
54.
Banik
SSR
,
Guo
C
,
Smith
AC
, et al
.
C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity
.
Mol Cell Biol
.
2002
;
22
(
17
):
6234
-
6246
.
10.1128/MCB.22.17.6234-6246.2002
55.
Gadalla
SM
,
Sales-Bonfim
C
,
Carreras
J
, et al
.
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita
.
Biol Blood Marrow Transplant
.
2013
;
19
(
8
):
1238
-
1243
.
10.1016/j.bbmt.2013.05.021
56.
Yabe
M
,
Yabe
H
,
Hattori
K
, et al
.
Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation
.
Bone Marrow Transplant
.
1997
;
19
(
4
):
389
-
392
.
10.1038/sj.bmt.1700674
57.
Barbaro
P
,
Vedi
A.
Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature
.
Biol Blood Marrow Transplant
.
2016
;
22
(
7
):
1152
-
1158
.
10.1016/j.bbmt.2016.03.001
58.
Fioredda
F
,
Iacobelli
S
,
Korthof
ET
, et al
.
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita
.
Br J Haematol
.
2018
;
183
(
1
):
110
-
118
.
10.1111/bjh.15495
59.
Feurstein
S
,
Zhang
L
,
DiNardo
CD.
Accurate germline RUNX1 variant interpretation and its clinical significance
.
Blood Adv
.
2020
;
4
(
24
):
6199
-
6203
.
10.1182/bloodadvances.2020003304
60.
Seimiya
H
,
Sawada
H
,
Muramatsu
Y
, et al
.
Involvement of 14-3-3 proteins in nuclear localization of telomerase
.
EMBO J
.
2000
;
19
(
11
):
2652
-
2661
.
10.1093/emboj/19.11.2652
61.
Laprade
H
,
Querido
E
,
Smith
MJ
, et al
.
Single-molecule imaging of telomerase RNA reveals a recruitment-retention model for telomere elongation
.
Mol Cell
.
2020
;
79
(
1
):
115
-
126.e6
.
10.1016/j.molcel.2020.05.005
62.
Zaug
AJ
,
Podell
ER
,
Nandakumar
J
,
Cech
TR.
Functional interaction between telomere protein TPP1 and telomerase
.
Genes Dev
.
2010
;
24
(
6
):
613
-
622
.
10.1101/gad.1881810
63.
Chu
TW
,
D’Souza
Y
,
Autexier
C.
The Insertion in Fingers Domain in human telomerase can mediate enzyme processivity and telomerase recruitment to telomeres in a TPP1-dependent manner
.
Mol Cell Biol
.
2015
;
36
(
1
):
210
-
222
.
10.1128/MCB.00746-15
64.
Georges
GE
,
Doney
K
,
Storb
R.
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
.
Blood Adv
.
2018
;
2
(
15
):
2020
-
2028
.
10.1182/bloodadvances.2018021162
65.
Orazi
A
,
Czader
MB.
Myelodysplastic syndromes
.
Am J Clin Pathol
.
2009
;
132
(
2
):
290
-
305
.
10.1309/AJCPRCXX4R0YHKWV
66.
Luo
X
,
Feurstein
S
,
Mohan
S
, et al
.
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
.
Blood Adv
.
2019
;
3
(
20
):
2962
-
2979
.
10.1182/bloodadvances.2019000644
You do not currently have access to this content.

Sign in via your Institution

Sign In